Automated CD34+ cell isolation of peripheral blood stem cell apheresis product

Cytotherapy

Volumn 17, Issue 10, 2015, Pages 1465-1471

  Spohn, Gabriele ^a   Wiercinska, Eliza ^a   Karpova, Darja ^b   Bunos, Milica ^a   Hümmer, Christiane ^a   Wingenfeld, Eva ^a   Sorg, Nadine ^a   Poppe, Carolin ^a   Huppert, Volker ^c   Stuth, Juliane ^c   Reck, Kristina ^c   Essl, Mike ^c   Seifried, Erhard ^a,b   Bönig, Halvard ^a,b,d  

^a Institute Frankfurt   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c MILTENYI BIOTEC GMBH   (Germany)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Allogeneic; Automation; CD34; Cell therapy; Clean room; CliniMACS; Good manufacturing practice; Haplo identical; Immunomagnetic; Naked haplo; Prodigy; Stem cell transplantation

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; CD34 ANTIGEN; LYMPHOCYTE ANTIBODY;

APHERESIS; ARTICLE; AUTOMATION; B LYMPHOCYTE; CD34 SELECTION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FREEZE THAWING; FREEZING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SHELF LIFE; STORAGE; T CELL DEPLETION; T LYMPHOCYTE; CELL CULTURE; CELL SEPARATION; CYTOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOMAGNETIC SEPARATION; LABORATORY AUTOMATION; LYMPHOCYTE DEPLETION; PROCEDURES;

ANTIGENS, CD34; ANTILYMPHOCYTE SERUM; AUTOMATION, LABORATORY; B-LYMPHOCYTES; BLOOD COMPONENT REMOVAL; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES;

EID: 84940891540     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2015.04.005     Document Type: Article

References (21)

1. Urbano-Ispizua A., Rozman C., Martinez C., Marin P., Briones J., Rovira M., et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. Blood 1997, 89:3967-3973.
2. Nakamura R., Auayporn N., Smith D.D., Palmer J., Sun J.Y., Schriber J., et al. Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant 2008, 14:449-457.
3. Pasquini M.C., Devine S., Mendizabal A., Baden L.R., Wingard J.R., Lazarus H.M., et al. Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. J Clin Oncol 2012, 30:3194-3201.
4. Kekre N., Antin J.H. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood 2014, 124:334-343.
5. Aversa F., Kröger N. Selected CD34+ Stem Cells for Graft Engineering 2015, Georg Thieme Verlag KG, Stuttgart.
6. Vogel W., Scheding S., Kanz L., Brugger W. Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC). Stem Cells 2000, 18:87-92.
7. Kawabata Y., Hirokawa M., Komatsuda A., Sawada K. Clinical applications of CD34+ cell-selected peripheral blood stem cells. Ther Apher Dial 2003, 7:298-304.
8. Bosio A., Huppert V., Donath S., Hennemann P., Malchow M., Heinlein U.A. Isolation and enrichment of stem cells. Adv Biochem Eng Biotechnol 2009, 114:23-72.
9. Barrett D., Fish J.D., Grupp S.A. Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. Pediatr Clin North Am 2010, 57:47-66.
10. Sorensen J., Jarisch A., Smorta C., Kohl U., Bader P., Seifried E., et al. Pediatric apheresis with a novel apheresis device with electronic interface control. Transfusion 2013, 53:761-765.
11. Pasquini M.C., Voltarelli J., Atkins H.L., Hamerschlak N., Zhong X., Ahn K.W., et al. Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2012, 18:1471-1478.
12. Keever-Taylor C.A., Devine S.M., Soiffer R.J., Mendizabal A., Carter S., Pasquini M.C., et al. Characteristics of CliniMACS(R) System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. Biol Blood Marrow Transplant 2012, 18:690-697.
13. Mueller M.M., Bialleck H., Bomke B., Brauninger S., Varga C., Seidl C., et al. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study. Vox Sang 2013, 104:46-54.
14. Brauninger S., Bialleck H., Thorausch K., Seifried E., Bonig H. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5.0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial. Vox Sang 2011, 101:237-246.
15. Brauninger S., Bialleck H., Thorausch K., Felt T., Seifried E., Bonig H. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems. Transfusion 2012, 52:1137-1145.
16. Dauber K., Becker D., Odendahl M., Seifried E., Bonig H., Tonn T. Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD stem cell enumeration kit. Cytotherapy 2011, 13:449-458.
17. Sorg N., Poppe C., Bunos M., Wingenfeld E., Hümmer C., Krämer A., et al. Erythrocyte depletion from bone marrow and peripheral blood buffy coat-a comparison of two new and three established technologies. Transfusion 2015, 55:1275-1282.
18. Apel M., Brüning M., Granzin M., Essl M., Stuth J., Blaschke J., et al. Integrated clinical scale manufactering system for cellular products derived by magnetic cell separation, centrifugation and cell culture. Chemie Ingenieur Technik 2013, 85:103-110.
19. Shpall E.J., Gehling U., Cagnoni P., Purdy M., Hami L., Gee A.P. Isolation of CD34-positive hematopoietic progenitor cells. Immunomethods 1994, 5:197-203.
20. Beaujean F. Methods of CD34+ cell separation: comparative analysis. Transfus Sci 1997, 18:251-261.
21. Hahn S., Sireis W., Hourfar K., Karpova D., Dauber K., Kempf V.A., et al. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates. Bone Marrow Transplant 2014, 49:338-348.